Brian Cheng
Stock Analyst at J.P. Morgan
(4.50)
# 1,092
Out of 4,994 analysts
282
Total ratings
50.2%
Success rate
12.4%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics | Reiterated: Buy | n/a | $25.25 | - | 2 | Sep 18, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | n/a | $38.22 | - | 27 | Sep 17, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | n/a | $71.86 | - | 6 | Sep 15, 2026 | |
| DNTH Dianthus Therapeutics | Initiated Coverage: Buy | $135 | $98.35 | +37.26% | 1 | Sep 11, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $121 → $140 | $122.06 | +14.70% | 8 | Sep 3, 2026 | |
| XNCR Xencor | Reiterated: Hold | $14 → $21 | $25.16 | -16.53% | 16 | Sep 3, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $33 | $27.57 | +19.72% | 14 | Sep 3, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $246 | $192.86 | +27.55% | 18 | Sep 1, 2026 | |
| PTGX Protagonist Therapeutics | Reiterated: Buy | $149 | $145.07 | +2.71% | 24 | Aug 31, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Hold | n/a | $1.71 | - | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.98 | +222.94% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.14 | - | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $13 | $6.50 | +100.00% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $27 | $12.60 | +114.29% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $37.29 | +34.08% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $29 | $23.34 | +24.25% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $72 | $58.11 | +23.90% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $25.93 | +69.69% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $25.53 | +80.18% | 1 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $89 → $91 | $65.96 | +37.96% | 10 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.68 | - | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.75 | - | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $7.51 | +286.15% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $12.69 | -36.96% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $77.74 | +23.49% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 → $46 | $15.87 | +189.86% | 6 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.92 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 → $67 | $59.03 | +13.50% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.73 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $10.71 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.89 | n/a | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.23 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.30 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.14 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $9.15 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.3156 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $11.69 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $3.5 | $1.90 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $8.78 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.8926 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $86 | $14.38 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.93 | n/a | 2 | Nov 2, 2021 |
BlossomHill Therapeutics
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.25
Upside: -
Roivant Sciences
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $38.22
Upside: -
Arrowhead Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $71.86
Upside: -
Dianthus Therapeutics
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $135
Current: $98.35
Upside: +37.26%
Kymera Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $121 → $140
Current: $122.06
Upside: +14.70%
Xencor
Sep 3, 2026
Reiterated: Hold
Price Target: $14 → $21
Current: $25.16
Upside: -16.53%
Zymeworks
Sep 3, 2026
Reiterated: Buy
Price Target: $33
Current: $27.57
Upside: +19.72%
Revolution Medicines
Sep 1, 2026
Reiterated: Buy
Price Target: $246
Current: $192.86
Upside: +27.55%
Protagonist Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $149
Current: $145.07
Upside: +2.71%
Allogene Therapeutics
Aug 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.71
Upside: -
Aug 17, 2026
Reiterated: Buy
Price Target: $29
Current: $8.98
Upside: +222.94%
Aug 17, 2026
Reiterated: Sell
Price Target: n/a
Current: $1.14
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: $10 → $13
Current: $6.50
Upside: +100.00%
Aug 10, 2026
Reiterated: Buy
Price Target: $31 → $27
Current: $12.60
Upside: +114.29%
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $37.29
Upside: +34.08%
Aug 10, 2026
Reiterated: Buy
Price Target: $26 → $29
Current: $23.34
Upside: +24.25%
Aug 10, 2026
Reiterated: Buy
Price Target: $65 → $72
Current: $58.11
Upside: +23.90%
Aug 6, 2026
Reiterated: Buy
Price Target: $44
Current: $25.93
Upside: +69.69%
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $25.53
Upside: +80.18%
Jul 13, 2026
Reiterated: Buy
Price Target: $89 → $91
Current: $65.96
Upside: +37.96%
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.68
Upside: -
Jun 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.75
Upside: -
May 13, 2026
Rated: Buy
Price Target: $29
Current: $7.51
Upside: +286.15%
May 13, 2026
Reiterated: Sell
Price Target: $8
Current: $12.69
Upside: -36.96%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $77.74
Upside: +23.49%
Apr 15, 2026
Reiterated: Buy
Price Target: $47 → $46
Current: $15.87
Upside: +189.86%
Mar 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.92
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $69 → $67
Current: $59.03
Upside: +13.50%
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.73
Upside: -
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $10.71
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $7.89
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.23
Upside: n/a
Jul 15, 2024
Reiterated: Hold
Price Target: n/a
Current: $1.30
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.14
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $9.15
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.3156
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $11.69
Upside: n/a
Apr 19, 2022
Reiterated: Buy
Price Target: $33 → $3.5
Current: $1.90
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $8.78
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.8926
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $93 → $86
Current: $14.38
Upside: n/a
Nov 2, 2021
Reiterated: Buy
Price Target: $14
Current: $1.93
Upside: n/a